New diabetes clinical trial: Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Published on: September 23, 2022 at 09:30PM
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Tirzepatide; Drug: Insulin Glargine
Sponsor: Nanjing First Hospital, Nanjing Medical University
Recruiting
https://ift.tt/J24ajDC
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Tirzepatide; Drug: Insulin Glargine
Sponsor: Nanjing First Hospital, Nanjing Medical University
Recruiting
https://ift.tt/J24ajDC
Comments
Post a Comment